BVX20 is a human monoclonal antibody that binds to CD20. It can eliminate B cells by engaging the immune system. BVX20 is applicable in the study of relapsed or chemotherapy-resistant follicular B-cell non-Hodgkin lymphoma (NHL), as well as CD20-positive diffuse large B-cell non-Hodgkin lymphoma (NHL).
Target-Kategorie:
Immunology/Inflammation related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
